Physician
Boston Children's Health Physicians of New Jersey, LLC
Boston Children's Health Physicians of New Jersey, LLC was paid $23.51M by Medicaid between Jan 2019 and Dec 2024, across 138 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.
33Billing provider infoBOSTON CHILDREN'S HEALTH PHYSICIANS OF NEW JERSEY, LLC
VALHALLA, NY 10595
VALHALLA, NY 10595
33aNPI1598213407assigned 09/20/2016
33bProvider typePediatrics Physician
28Total paid$23.51M
24GClaims467,616
24DCodes billed138
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#6 of 1,983
Median peer was paid$17K
This provider vs. median1,385×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 42,857 | $2.02M | |
| 2020 | 52,501 | $2.21M | |
| 2021 | 104,940 | $4.09M | |
| 2022 | 120,437 | $5.49M | |
| 2023 | 93,974 | $5.77M | |
| 2024incomplete | 52,907 | $3.92M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 43,428 | 40,962 | $6.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 57,438 | 53,356 | $5.54M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 15% | 16,488 | 15,538 | $3.51M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.4% | 35,188 | 34,854 | $799K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.8% | 5,519 | 5,508 | $658K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.6% | 5,189 | 5,182 | $617K |
| 99460 | 2.2% | 4,531 | 4,526 | $522K | |
| 99222 | Initial hospital care, per day, moderate complexity | 2.0% | 2,881 | 2,878 | $477K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.0% | 4,193 | 4,117 | $464K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 2,916 | 2,912 | $377K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1.5% | 3,748 | 3,742 | $352K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.5% | 10,030 | 9,709 | $348K |
126 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.5% | 1,623 | $346K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.3% | 2,218 | $312K |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 1.2% | 540 | $278K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 2,377 | $210K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,930 | $201K |
| 95812 | <1% | 541 | $180K | |
| 96112 | <1% | 1,694 | $169K | |
| 95700 | <1% | 589 | $146K | |
| 92587 | <1% | 3,953 | $133K | |
| 99205 | Prolong outpt/office vis | <1% | 490 | $133K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,349 | $126K |
| 95708 | <1% | 690 | $117K | |
| 99464 | <1% | 785 | $68K | |
| 87631 | <1% | 591 | $65K | |
| 99462 | <1% | 1,259 | $64K | |
| 94010 | <1% | 2,090 | $61K | |
| 90837 | Psychotherapy session, about an hour | <1% | 325 | $60K |
| 99051 | <1% | 9,168 | $57K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 351 | $57K |
| 99441 | <1% | 924 | $56K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,323 | $53K |
| 95720 | <1% | 250 | $52K | |
| 99468 | <1% | 50 | $52K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 362 | $47K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,813 | $45K |
| 92551 | <1% | 4,638 | $42K | |
| 93000 | <1% | 2,834 | $41K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 214 | $41K |
| 96160 | <1% | 15,974 | $40K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 593 | $37K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 282 | $37K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,584 | $37K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 759 | $32K |
| 87428 | <1% | 651 | $31K | |
| 96127 | <1% | 5,031 | $30K | |
| 99443 | <1% | 233 | $30K | |
| 93325 | <1% | 1,743 | $27K | |
| 92552 | <1% | 931 | $23K | |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 154 | $21K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 153 | $20K |
| 87634 | <1% | 251 | $18K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 168 | $17K |
| 95719 | <1% | 86 | $16K | |
| 93320 | <1% | 383 | $14K | |
| 99442 | <1% | 126 | $13K | |
| 99245 | <1% | 107 | $13K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 92 | $12K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,303 | $11K |
| 85018 | <1% | 4,814 | $10K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 68 | $9K |
| 99223 | Prolong inpt eval add15 m | <1% | 38 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,098 | $7K |
| 99417 | Prolong home eval add 15m | <1% | 157 | $7K |
| 87070 | <1% | 760 | $6K | |
| 90785 | <1% | 294 | $5K | |
| 81000 | <1% | 1,169 | $5K | |
| 92060 | <1% | 60 | $5K | |
| 87081 | <1% | 942 | $4K | |
| 86580 | <1% | 352 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 407 | $3K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 15 | $3K |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 18 | $3K |
| 81002 | <1% | 962 | $2K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 13 | $2K |
| 0071A | <1% | 53 | $2K | |
| 93040 | <1% | 816 | $2K | |
| 99381 | <1% | 15 | $2K | |
| 90686 | <1% | 7,791 | $2K | |
| 83655 | <1% | 138 | $2K | |
| 69210 | <1% | 28 | $2K | |
| 90620 | <1% | 27 | $2K | |
| 94664 | <1% | 185 | $1K | |
| 81003 | <1% | 624 | $1K | |
| 90734 | <1% | 508 | $1K | |
| 92558 | <1% | 1,269 | $980.70 | |
| 99050 | <1% | 146 | $956.90 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 40 | $822.14 |
| 95816 | <1% | 12 | $738.12 | |
| 96161 | <1% | 445 | $726.99 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 168 | $615.84 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 55 | $534.05 |
| 0072A | <1% | 12 | $493.32 | |
| 94760 | <1% | 16,811 | $487.61 | |
| 92550 | <1% | 33 | $421.08 | |
| 82272 | <1% | 257 | $363.78 | |
| 95012 | <1% | 12 | $343.98 | |
| 99429 | <1% | 15 | $258.75 | |
| A4206 | Syringe with needle, sterile, 1 cc or less, each | <1% | 4,135 | $249.95 |
| 36410 | <1% | 35 | $245.70 | |
| 92553 | <1% | 13 | $244.66 | |
| 99177 | <1% | 1,217 | $211.98 | |
| 82947 | <1% | 55 | $192.57 | |
| 90715 | <1% | 177 | $187.00 | |
| 99188 | <1% | 13 | $184.99 | |
| 90716 | <1% | 319 | $160.00 | |
| 87807 | <1% | 12 | $157.20 | |
| 90656 | <1% | 332 | $156.45 | |
| 99253 | <1% | 19 | $132.48 | |
| 90707 | <1% | 693 | $90.00 | |
| 90461 | <1% | 6,054 | $81.00 | |
| 82465 | <1% | 15 | $65.25 | |
| 90661 | <1% | 90 | $34.00 | |
| 99173 | <1% | 4,740 | $15.45 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,052 | $1.71 |
| 90698 | 0% | 173 | $0.00 | |
| 90680 | 0% | 52 | $0.00 | |
| 99000 | 0% | 4,356 | $0.00 | |
| 36416 | 0% | 5,201 | $0.00 | |
| 90723 | 0% | 1,694 | $0.00 | |
| 91307 | 0% | 164 | $0.00 | |
| 90647 | 0% | 681 | $0.00 | |
| 90677 | 0% | 225 | $0.00 | |
| 90696 | 0% | 132 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 16 | $0.00 |
| 99255 | 0% | 12 | $0.00 | |
| 90651 | 0% | 56 | $0.00 | |
| 90619 | 0% | 12 | $0.00 | |
| 99072 | 0% | 108,216 | $0.00 | |
| 90670 | 0% | 1,527 | $0.00 | |
| 99367 | 0% | 89 | $0.00 | |
| 92015 | Determination of refractive state | 0% | 137 | $0.00 |
| 90648 | 0% | 80 | $0.00 | |
| 98960 | 0% | 16 | $0.00 | |
| 91300 | 0% | 16 | $0.00 | |
| 90633 | 0% | 27 | $0.00 | |
| 97803 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFINKELSTEIN, JONATHAN (OWNER)